Citizen1 is Discovery Tools (Healthcare) in United States that focus on drug development information business. Founded in 1996. They cover business area such as Provider, research and development service, pharmaceutical and biotechnology industry, clinical trial, drug development information, TrialTrove, SiteTrove, detailed profile, TrialScape, graphical representation, CustomAnalytics, design, implementation, plan trial.
1996
( 28 years old in 2024 )
Drug Development Information
-
52 Vanderbilt Avenue
Seventh Floor
New York, NY 10017
United States
Private
Providerresearch and development servicepharmaceutical and biotechnology industryclinical trialdrug development informationTrialTroveSiteTrovedetailed profileTrialScapegraphical representationCustomAnalyticsdesignimplementationplan trial
* We use standard office opening hours in near Citizen1's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Citizen1 is Discovery Tools (Healthcare) business from United States that founded in 1996 (28 years old in 2024), Citizen1 business is focusing on Drug Development Information.
Citizen1 headquarter office and corporate office address is located in 52 Vanderbilt Avenue Seventh Floor New York, NY 10017 United States.
Citizen1 was founded in United States.
In 2024, Citizen1 is currently focus on drug development information sector.
Above is snippet of Google Trends for "drug development information" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Citizen1, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
